From patient selection to predictive modeling, leading sponsors are incorporating AI to drive efficiency gains of 30–70% in clinical development, thereby accelerating timelines and boosting success rates (McKinsey, 2023).

Yet, despite the promise, many AI initiatives introduce more risk than they mitigate—not because the technology falls short, but because implementation fails. Internal build teams may have strong technical talent, but they often lack the cross-functional structure, dedicated resources, and organizational trust needed to drive adoption. Timelines drag, regulatory confidence wanes, and new tools can go unused because no one is empowered to carry them forward. Even capable teams struggle to manage the change required to use what they’ve built.

External vendors face a different but equally limiting challenge. Many can deliver promising models, but few understand how to deploy those models into the tightly coordinated processes that bring drugs to market. Without alignment across clinical, statistical, and regulatory functions, even the most advanced solutions stall at the point of execution.

Unlearn bridges the gap between innovation and execution by embedding AI into trials with cross-functional support that directly incorporates into your team’s workflows. Here’s how.

Your Strategic AI Partner

When you partner with Unlearn, you gain an extension of your team—one that understands how clinical trial teams operate and can fill the resource or expertise gaps that can stall high-priority projects. We ensure seamless collaboration between internal and external stakeholders, allowing your scientific leaders to shine so innovation isn’t stalled by operational complexity. 

Each engagement is led by a Solution Scientist, a senior scientific partner responsible for aligning goals, ensuring scientific integrity, and guiding project execution. They’re supported by a Relationship Manager who manages communication, scheduling, and project tracking throughout the partnership. Together, they coordinate a broader team of Unlearn specialists, each aligned with sponsor counterparts.

This embedded approach eliminates the disconnect that often occurs when vendors operate in silos or require sponsors to translate technical deliverables into trial-ready outputs. Unlearn’s team manages that full scope so you don’t need to reorganize internally or stand up a new AI function. We’ve already done the work to make that unnecessary.

Sponsors often struggle to align clinical, statistical, regulatory, and data functions internally. Unlearn reduces that friction by delivering an integrated team from the start, resourced and ready to deliver on complex, cross-disciplinary initiatives.

AI Built for Clinical Trials 

With Unlearn, your team is equipped to lead. Our proprietary Digital Twin Generators (DTGs) forecast each trial participant’s trajectory under control across all clinical outcomes, subscales, and biomarkers, enabling your scientists to conduct hyper-granular analyses and explore “what-if” scenarios. 

DTGs are disease-specific, rigorously validated, and used in trials for Alzheimer’s, ALS, Parkinson’s, and other complex indications. Combined with PROCOVA, our method for using digital twins qualified by the EMA and supported by the FDA, these tools help your team make confident, regulatory-aligned decisions.

This combination of AI modeling and regulatory coordination is rare, and it’s what allows Unlearn to operate in high-stakes environments where other AI partners fall short.

Flexible Delivery to Meet You Where You Are

• Full-Service Model: Unlearn sources the data, builds the models, and delivers results end-to-end.
• Custom Infrastructure Support: Unlearn integrates within your environment to build secure, proprietary solutions using your data.

Delivering Real World Impact 

No matter how you choose to engage, Unlearn’s AI solutions are designed to fit within your existing clinical ecosystem, not force you to create a new one.

We’ve delivered for global pharma companies like J&J, AbbVie, and Roche, supporting trials from SAP development to regulatory submissions—without requiring sponsors to re-architect their internal teams.

That’s what makes us different, and why sponsors partner with us when they want to move quickly, confidently, and with clarity.